Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D001854:Bone Marrow Cells; D004359:Drug Therapy, Combination; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000302:isolation & purification; D007938:Leukemia / Q000139:chemically induced / Q000150:complications*; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology / Q000473:pathology; D007958:Leukocyte Count; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013577:Syndrome
D000970:Antineoplastic Agents; D006454:Hemoglobins; D007136:Immunoglobulins; D008558:Melphalan; D011241:Prednisone